{
    "organizations": [],
    "uuid": "c0e928850e6e090c48e76ecfaf038a02f014e234",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-botanix-pharmaceuticals-posts-hy-l/brief-botanix-pharmaceuticals-posts-hy-loss-attributable-2-4-million-idUSFWN1QG0FJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Botanix Pharmaceuticals Posts HY ‍Loss Attributable $2.4 Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 26 (Reuters) - Botanix Pharmaceuticals Ltd:\n* HY ‍LOSS ATTRIBUTABLE TO OWNERS $2.4 MILLION VERSUS LOSS OF $1.2 MILLION\n* HY REVENUES FROM ‍ ORDINARY ACTIVITIES $1.8 MILLION VERSUS $10,937 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-26T18:17:00.000+02:00",
    "crawled": "2018-02-27T15:12:57.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "botanix",
        "pharmaceutical",
        "ltd",
        "hy",
        "attributable",
        "owner",
        "million",
        "versus",
        "loss",
        "million",
        "hy",
        "revenue",
        "ordinary",
        "activity",
        "million",
        "versus",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}